The Scottish Medicines Consortium (SMC) which advises on newly licensed medicines for use by NHSScotland has today (Monday 8 November) published advice acceptin... Read More...
• High blood cholesterol increases the risk of cardiovascular disease (CVD), which was the leading
cause of death in Scotland in 2020, equating to nearly 50 pe... Read More...
The Scottish Medicines Consortium (SMC) has today announced that Ofev® (nintedanib) has been accepted for use by NHSScotland for the treatment of adult patients... Read More...
Healthcare Professional ONLY
This website is intended for Healthcare professionals only
Are you a qualified pharmacist or health professional?
By continuing to access this site, you are consenting to viewing promotional product information provided by our pharmaceutical company sponsors
